Yi Kuang Selected Research

Yi Kuang Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 12/2011
7	Infections 10/2022 - 09/2009
5	Human Influenza (Influenza) 10/2022 - 05/2010
4	Leukemia 01/2024 - 12/2022
4	Inflammation (Inflammations) 01/2023 - 05/2010
3	COVID-19 04/2023 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 10/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 01/2021
2	Insulin Resistance 02/2022 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 11/2015
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2020
2	Virus Diseases (Viral Diseases) 11/2016 - 11/2009
1	Breast Neoplasms (Breast Cancer) 02/2024
1	Chronic Disease (Chronic Diseases) 07/2023
1	Acute Erythroblastic Leukemia (Erythroleukemia) 04/2023
1	Sepsis (Septicemia) 02/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 12/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2022
1	Acute Lung Injury 11/2022
1	Diabetes Mellitus 02/2022
1	Ulcerative Colitis 10/2020
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2020
1	Mite Infestations (Mange) 10/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Bites and Stings (Sting) 01/2020
1	vitreous floaters 11/2018
1	Fatigue 08/2018

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 02/2023 - 05/2010
4	EnzymesIBA 01/2023 - 11/2015
3	Transcription Factors (Transcription Factor)IBA 03/2024 - 12/2022
3	Peptides (Polypeptides)IBA 09/2023 - 01/2016
3	Small Interfering RNA (siRNA)IBA 04/2023 - 12/2022
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 10/2014
3	ChemokinesIBA 05/2010 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2016
2	AntioxidantsIBA 12/2022 - 12/2018
2	Ethanol (Ethyl Alcohol)IBA 12/2022 - 01/2018
2	Immunoglobulin G (IgG)IBA 10/2022 - 10/2020
2	antcin KIBA 02/2022 - 07/2017
2	TriterpenesIBA 01/2022 - 01/2021
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 07/2014
2	HydrogelsIBA 01/2016 - 07/2014
2	DipeptidesIBA 10/2014 - 12/2011
1	ErbB Receptors (EGF Receptor)IBA 02/2024
1	Proto-Oncogene Proteins c-etsIBA 01/2024
1	ChromatinIBA 01/2024
1	CholesterolIBA 04/2023
1	Lovastatin (Mevacor)FDA LinkGeneric 04/2023
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 04/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023
1	cleomiscosin CIBA 04/2023
1	LipidsIBA 02/2023
1	Angiopoietin-2IBA 02/2023
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 02/2023
1	diacereinIBA 01/2023
1	Carboxy-LyasesIBA 01/2023
1	tetrandrineIBA 01/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Pyruvic Acid (Pyruvate)IBA 12/2022
1	dehydroeburicoic acidIBA 12/2022
1	schaftosideIBA 11/2022
1	LipopolysaccharidesIBA 11/2022
1	Immunoglobulin M (IgM)IBA 10/2022
1	Inactivated VaccinesIBA 10/2022
1	danhongIBA 09/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Glycyrrhetinic Acid (Po 12)IBA 01/2022
1	SaponinsIBA 01/2022
1	Terpenes (Terpenoids)IBA 01/2021
1	Huang QiIBA 01/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2020
1	Dextran SulfateIBA 10/2020
1	Inositol (Myoinositol)IBA 03/2020
1	AlkaloidsIBA 03/2020
1	tirucallaneIBA 03/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	AntibodiesIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	myricetinIBA 12/2019
1	jugloneIBA 11/2019
1	Circular RNAIBA 10/2019
1	AluminumIBA 11/2018
1	YttriumIBA 11/2018
1	asphaltIBA 08/2018
1	ethyl acetateIBA 01/2018
1	Phenolsulfonphthalein (Phenol Red)IBA 01/2018

Therapy/Procedure

5	Therapeutics 02/2023 - 01/2013
2	Immunotherapy 01/2020 - 01/2020
1	Long-Term Care 07/2023
1	Drug Tapering 10/2020
1	Solid-State Lasers 11/2018